The ability of fusion proteins to facilitate EGFR ubiquitination and subsequent degradation provides a novel strategy for reducing EGFR signaling, which is a key process implicated in the growth and progression of lung cancer (Waterman et al., 2014; Zhong et al., 2015). The gene discussed is EGFR; the disease is lung cancer.